Sampre Nutritions Ltd has entered a 3-year manufacturing agreement with Rama Exports valued at ₹15 crore. This collaboration strengthens its nutraceutical and food operations while the company continues to report significant growth in revenue and profit.
Sampre Nutritions signed a manufacturing agreement with Rama Exports for nutraceutical and food products. Under the deal, Sampre will take charge of manufacturing, supply, packaging, and quality assurance in line with its brand standards. Rama Exports will acquire the products at agreed prices during the 3-year period of the deal.
The agreement is expected to generate ₹15 crore in business and enhance Sampre’s foothold in the nutraceutical and food segment.
The company delivered a strong performance in Q1FY26 with revenue from operations at ₹10.87 crore compared to ₹4.51 crore in Q1FY25, reflecting 141% Y-o-Y growth.
Net Profit surged 615% to ₹70.76 lakh from ₹9.89 lakh reported in the same quarter last year. The Earnings Per Share (EPS) stood at ₹0.34 compared to ₹0.11 in Q1FY25, signalling improved profitability and operational efficiency.
Further showcasing its industry credibility, the company secured the Certificate of Recognition under the India 5000 Best MSME Awards 2024 for quality excellence. Sampre is also recognised as the 1st ISO certified confectionery manufacturer in South East Asia since 1995 and continues to hold HACCP and FSSA Version 6 certifications, underscoring its compliance with global standards.
Read More: Patanjali Foods Shareholders Approve 2:1 Bonus Share Issue; Share Price in Focus!
In line with its growth strategy, Sampre has proposed a fundraising initiative through qualified institutional placement, preferential issue, and other routes. A board meeting will be held to seek shareholder approval for this plan.
Earlier, in November 2024, the company allotted 8,40,000 warrants to non-promoters at ₹60.50 per warrant, each convertible into one equity share of face value ₹10.
On August 26, 2025, Sampre Nutritions share price opened at ₹74.00 on BSE, above the previous close of ₹72.56. The stock is trading at ₹75.47 as of 10:52 AM. The stock hit an upper circuit of 2%.
Over the past week, it has moved up by 8.22%, over the past month, it has moved up by 48.32%, and over the past 3 months, it has moved up by 164.60%.
Sampre Nutritions’ agreement with Rama Exports worth ₹15 crore marks a significant move in its nutraceutical growth journey. Reinforced by strong Q1FY26 results, recognised certifications, and strategic fundraising plans, the company continues to position itself for sustainable expansion across food and nutraceutical segments.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in securities are subject to market risks. Read all related documents carefully before investing.
Published on: Aug 26, 2025, 12:38 PM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
